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Summary 
Infections with Bovine Viral Diarrhoea Virus (BVD) are endemic in cattle populations 
worldwide and result in major economic losses; hence, many countries have begun BVD 
eradication programs. The authors estimated the losses caused by BVD, and the estimated 
annual losses in 2012 amounted to 4.5 million EUR in Hungary. In a dairy cattle farm with 
1000 cows the acute clinical BVD could cause more than 166,264 EUR estimated yearly loss 
and the BVD-MD could be blamed for more than 10,203 EUR loss per year on average. The 
presented losses are probably underestimated as some disease effects are difficult to quantify, 
though they can indicate the income realizable in case of freedom from the disease, so can be 
the starting point of cost-benefit analysis of an eradication program. In the early 2000s, the 
control studies have shown that the seropositivity in northern and western European countries 
ranged between 1-95%. Systematic BVD control aims to deliver a targeted reduction in the 
prevalence of BVD virus on sectoral, regional or national basis. In the Scandinavian countries, 
the eradication program is based on detecting and removal of PI animals without the use of 
vaccines. These programmes have been very successful, and by the late 2000s, the cattle herds’ 
BVD infection in Scandinavia decreased below 0.1%, but in several western and southern 
European countries, the prevalence still ranged between 35-90%. In Hungary, the 
seropositivity was 40-50% in the 1970s, 60-70% in the 1980s, and 95% in 1999. The latest 
survey data in 2008 showed that the infection rate was 67.8% and 42.5% for herds and 
animals, respectively. The eradication has been obligatory in Lower-Austria since 2004, in 
Switzerland since 2008 and in Germany since 2011 with the use of vaccines. Mandatory 
eradication program started in Scotland in 2012, and began in Ireland in 2013 applying the 
Scandinavian method. 
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Introduction 
 
Bovine Viral Diarrhoea Virus (BVDV) is the denomination of a heterogeneous 
group of viruses in the family Flaviviridae, genus Pestivirus with two accepted 
genotypes or species (BVDV-1 and -2), which are economically important pathogens 
that primarily infect ruminants (Varga et al., 1999). Prevalence of BVDV-1 and 
BVDV-2 vary across the world: BVDV-2 represents around 50% of the virus isolates 
in North America, whereas BVDV-1 dominates in Europe, with more than 90% 
(Lindberg et al., 2006). Most isolates of both viral species are well adapted to cattle 
and acute infections with such low-virulent strains generally go unnoticed unless there 
are other contributing factors. According to their ability to cause cytopathic effect 
(CPE) in cell cultures, BVDV strains are classified as cytopathogenic (cp) or non-
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cytopathogenic (ncp) biotypes (Houe et al., 1995). Ncp is the most common naturally 
occurring biotype including BVDV-1 and BVDV-2 strains, and is the only biotype that 
can lead to persistent infections of BVDV. The cp biotype occurs much less 
frequently, cp BVDV strains were isolated almost exclusively from MD cases. Both cp 
and persisting ncp biotype can be simultaneously isolated from animals succumbing to 
MD. These isolates are called a ”virus pair” (Meyers and Thiel, 1996, Ramsey and 
Chivers, 1953). BVDV virulence varies markedly, and due to a transient 
immunosuppression acute infections are often exacerbated by secondary infections. 
This is how BVDV plays its role in other disease syndromes, including respiratory and 
enteric conditions. Bovine viral diarrhoea virus also interferes extensively with 
reproductive functions. Depending on the time of infection, there may be a significant 
reduction in conception rates and an increased number of abortions, malformations, 
stillbirths or births of persistently infected calves. The latter are immunotolerant to the 
persisting virus. 
Infection with BVDV can result in a wide spectrum of clinical diseases ranging 
from subclinical infections to a highly fatal form known as MD. In the typical cases 
the diagnosis is clear based on the observed clinical signs and lesions’ characteristics 
of animal. The majority (70-90%) of BVDV infections are subclinical. The likely 
source of these BVDV infections are cattle that are immunotolerant and persistently 
infected (PI) with ncp BVDV (Bálint, 2005). 
The accurary of available diagnostic test is crucial for the success of a control 
program. For BVDV infection, several diagnostic test, aiming either to detect the virus 
itself, virus components, virus antigens or to detect viral-specific antibodies, are 
available (Varga et al., 1999).  
In control programs, the performance of a diagnostic test, with regard to sensitivity 
and specificity, is highly dependent on the program’s objectives. For example, 
antibody detection in bulk milk or pooled blood/serum/plasma is useful in initial 
screening for classification of herd status, but is not useful for monitoring a recently 
cleared herd to reconfirm its status or detect reinfection. Available diagnostic tools 
must be evaluated according to the specific objectives or phase in the control or 
eradication program at the level of the herd and of the region (Houe et al. 2006). 
Virus isolation is usually considered the most reliable direct virus detection 
technique. Virus isolation requires cell culturing facilities which derived from kidney, 
testis or nasal turbinate epithelium of cattle. ELISA tests can be used for BVDV 
antigen detection. Antigen ELISAs have the advantage of being fast and inexpensive, 
obviating the need for cell culture facilities, and usually offering high sensitivity and 
specificity (Lindberg, 2003; Varga et al., 1999). The presence of BVDV ribonucleic 
acid (RNA) can be detected by reverse transcriptase-polymerase chain reaction (RT-
PCR). This technique offers high sensitivity, making it suitable for testing specimens 
with potentially low quantities of virus, as well as PI animals, or other biological 
materials (Belák and Pallagi-Pordány, 1991). The most commonly used antibody 
detection techniques are the virus neutralisation test (VNT) and antibody-specific 
ELISAs (Becher et al., 2003). 
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The economic losses caused by BVD 
 
The prevention of infectious diseases, which cause severe clinical signs and high 
mortality, is essential and clear for everyone. Most of the infectious diseases, which 
cause great economic losses, has been eradicated from the European countries 
(including Hungary) or their incidence could be decreased significantly. However, in 
the cattle herds in most of the European countries (including Hungary), there are still 
some widely spread infectious disease which primarily appear in chronic forms. These 
diseases do not often cause clinical symptoms and mortality, but the production 
parameters are weakening and over a long period can cause significant financial losses 
to the producers. In Hungarian cattle herds there are two viral diseases appearing 
mainly in their chronic forms which cause great economic losses; the Bovine Viral 
Diarrhoea and Mucosal Disease (BVD–MD), and the Infectious Bovine 
Rhinotracheitis (IBR).  
The BVD is a major pathogen of cattle that causes significant economic losses 
worldwide in the cattle industry; for example in the Irish herds the annual total loss is 
estimated to be 102 million EUR (Byrne, 2010). An acute BVD outbreak has several 
negative effects on the production of dairy herds; it reduces the reproductive 
performance (more cows will remain empty), the milk production and the weight gain 
in calves, and increases the mortality rate, the risk of secondary infections and early 
culling (Ózsvári et al., 2001). The BVD virus can cause a wide range of lesions not 
merely in cattle with clinical signs but also in both infected cattle without any signs 
and in their progeny. In addition, the BVD virus has a strong immunosuppressive 
effect, which predisposes different diseases, such as pneumonia, mastitis, and diseases 
of bovine digits (Murphy, 2012).  
An acute BVD outbreak caused an estimated average loss of 85 EUR per cow in 
Ireland (Byrne, 2010), 137 EUR per cow in United Kingdom (Bennett and 
Mawhinney, 1999), 74 EUR per cow in the Netherlands (Wentink and Dijkhuizen, 
1990) and 59 EUR per cow in Denmark (Houe, 1994). The estimated average annual 
losses per cow caused by BVD are 34 EUR in Canada (Chi, 2002), 31 EUR in United 
Kingdom (Gunn et al., 2004) and 48 EUR in Ireland (SAC, 2010). 
 
The estimated annual losses caused by BVD in Hungary  
 
The BVDV occurs widely in the Hungarian large-scale dairy herds. The prevalence 
of the infected herds is estimated to be about 95% (Kudron, 1999; Ózsvári et al., 
2001). The annual risk of the introduction of the BVDV into intact herds, which are 
5% of all herds, is between 30-50%, that is, 1.5-2.5% of the total cattle population can 
have acute, clinical incidence of BVD yearly. The cattle of any age is exposed to the 
risk of infection but often certain age groups within a herd are affected by the disease 
(Kudron, 1999; Ózsvári et al., 2001). 
The estimated losses caused by BVD in Hungary, based on the national cattle 
population, and the average Hungarian price and production data of the year 2012, are 
shown in Table 1.  
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Table 1. The estimated losses caused by BVD in Hungary (thousand EUR/year) 
Sources of losses Low* High* 
  Drop in milk production 47.4 78.9 
  Abortion 26.3 525.6 
  Mortality of cows 38.9 1,296.4 
  Premature disposal of cows 97.2 890.8 
  Mortality of calves up to 1 year 1,196.4 4,785.7 
  Total loss per national herd 1,406.1 7,577.4 
  Total average loss per national herd 4,491.8 
  Total loss per cow (EUR) 4.3 23.1 
  Total average loss per cow (EUR) 13.7 
*Depending on annual risk of infection of the BVD negative herds (30 or 50%) and minimum and 
maximum effects of the disease on production (extreme values), low and high estimation of losses 
caused by BVD were carried out. 
Source: own calculations 
 
The annual estimated losses caused by BVD were approximately 4.5 million EUR 
on an average at national level, but if the rate of incidence is higher and the disease 
effects are more severe, the damage can come close to 7.6 million EUR. The loss per 
cow averaged 13.7 EUR yearly. 
The estimated losses caused by both acute clinical BVD and BVD-MD complex in 
a herd with 1000 cows are shown in Table 2 and 3.  
Table 2. The estimated losses caused by acute, clinical BVD in a dairy farm with 1000 
cows (EUR/year) 
Sources of losses Low High 
  Drop in milk production 9,627.0 
  Abortion 79.7 1,594.1 
  Mortality of cows 7,864.3 157,285.7 
  Premature disposal of cows 19,648.9 108,069.0 
  Mortality of calves or cattle up to 1 year 3,764.9 14,985.7 
  Total losses per herd 40,966.4 291,561.6 
  Total average losses per herd 166,264.0 
Source: own calculations 
 
Table 3. The estimated losses caused by BVD-MD in a dairy farm with 1000 cows 
(EUR/year) 
Sources of losses Low High 
  Abortion 79.7 1,594.1 
  Mortality of calves or cattle up to 1 year 3,764.9 14,985.7 
  Total losses per herd 3,826.1 16,579.8 
  Total average losses per herd 10,203.0 
Source: own calculations 
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The annual estimated losses per herd caused by acute BVD could be 166,264 EUR 
on an average, but if the disease effects are more severe, the damage can come close to 
291,561 EUR. The annual losses resulting from chronic BVD were estimated to be 
10,203 EUR per herd, but with severe disease impacts could exceed 16,579 EUR on 
herd-level. 
The extent of losses is likely to be underestimated compared to the real damages 
caused by BVD, since many effects of the disease are difficult to be estimated. Having 
acquired the relevant data the losses coming from the immunsupression, reproductive 
disorders, subclinical effects and drug treatments can also become calculable.  
The chronic BVD is also detrimental to the production parameters, hence, the 
control of chronic BVD infection can contribute to increase the profitability of dairy 
farms. 
 
Prevalance of BVD virus in Europe 
 
Infections with bovine viral diarrhoea virus are endemic in most cattle-producing 
countries throughout the world. Approximately 50% of all herds have PI animals, and 
90% of all cattle become exposed during their lifetime. In endemic areas, a high 
correlation between BVDV prevalence and cattle density has been shown. BVDV 
occurs in most of the cattle-producing countries and causes significant economic losses 
to the cattle industry. This led in several countries to carry out epidemiological, as well 
as, cost/benefit studies and initiate eradication or control programs (for example 
Denmark, Finland, Ireland, Norway, Sweden). Before starting these programs the 
seroprevalence in the EU ranged from less than 1% in Finland, through 19% in 
Norway, 46% in Sweden, 64% in Denmark to 95% in England (Greiser et al., 2003). 
Between 2009 and 2010 a study was conducted about seroprevalance of BVD in the 
EU. According to study findings the prevalence was between 35-90% in France and 
Italy, less than 10% in Austria, also less than 0,1% in Sweden and Denmark and was 
below 0,01% in Finland and Norway. Cattle herds of Great-Britain, Spain, Portugal, 
Germany, the Netherlands, Switzerland and Belgium had a BVDV prevalence rate 
more than 90% (Di Labio, 2011).  
In 2011 no BVD cases have been reported from Finland and Norway, and only two 
from Denmark, one of which was due to import of a BVDV vaccinated PI carrier from 
a non-free country. In Sweden two cases were detected in 2010 and one in 2011, all 
due to direct or indirect contact with herds still under investigation with suspected 
routes of transmission supported by molecular epidemiological investigations (Stahl 
and Alenius, 2012). 
In Hungary, BVDV was deemed to cause severe respiratory, enteritis and abortion 
cases in the late 1950’s (Áldásy and Szabó, 1959), but the virus was isolated only a 
few years later (Manninger  et al., 1963). The seroprevalence of BVDV in Hungary 
was 40-50% in the 1970s, 60-70% in the 1980s, and 95% in 1999 according to 
representative studies (Kudron, 1999). 
In Hungary between 2006 and 2008 a nationwide representative survey was carried 
on the prevalence of BVDV. 16 Hungarian counties (out of 19) participated in the 
survey (except for Vas, Nógrád and Heves counties) and in these counties 
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epidemiologically closed herds were randomly selected where there was no 
vaccination against BVD. In the selected cattle herds those animals were also 
randomly selected that did not show any clinical signs, and certainly did not have 
maternal antibodies. The laboratory tests were carried out by using the ELISA method, 
and 1,176 blood samples sent from 59 cattle herds. Out of the 1,176 samples 500 
proved to be positive (42.5%), 34 were doubtful (2.9%), while 642 were negative 
(54.6%). Regarding the cattle farms, out of 59 herds sending samples for investigation 
there were 40 having at least one BVD positive animal (67.8%), while among the 
blood samples of 19 herds no positive was identified (32.2%). Among these latter 
herds there were several ones, where the samples were collected from old cows 
milking already through several lactation periods, therefore the seronegativity clearly 
indicates the BVDV free status of the given herd. Even among the positive cattle herds 
we have found a few where the prevalence of seropositivite animals was rather low 
(<5%) (Mester, 2009). 
 
Eradication of BVD 
 
Control and prevention 
 
At present, in most parts of Europe, BVDV is being controlled mostly on a 
voluntary basis. Control and eradication of BVDV is possible either with or without 
vaccines. Vaccines are available in many countries, but the take-up rate is very varied, 
from below 20% up to 75% (Moening and Brownlie, 2006). The strategy of control or 
eradication of BVDV depends on national regulations and financial resources. In the 
United Kingdom, Ireland, the Netherlands and Slovenia, only inactivated BVDV 
vaccines are licensed. The Scandinavian countries and Austria do not permit the use of 
BVDV vaccines, instead, large-scale eradication schemes are in place. The first large-
scale eradication schemes were launched in 1993-1994 in the Shetland Islands, 
Denmark, Finland, Norway and Sweden (Lindberg et al., 2006). 
BVDV causes both transient and persistent infections and can escape from the 
host’s immune responses during both events. Transient infection occurs in cattle of all 
ages. Oronasal infection results in transient viraemia and virus excretion is low before 
it is eliminated by a standard immune response. However, if infection occurs in a 
pregnant animal, the virus escapes by crossing the placenta to the foetus where it 
infects a wide variety of cells without killing them. Before day 120 of the gestation a 
foetus lacks a mature adaptive immune response; all viral antigens are accepted as its 
own and are forever seemingly ignored by the foetus’ or the calf’s cell-mediated and 
humoral adaptive responses. The foetus becomes immunotolerant to these viral 
antigens and will not respond to them throughout the rest of its life. The virus has 
simply escaped from the host’s adaptive immune response, resulting in an animal that 
is persistenly infected (Nettleton, 2013). PI calf will continuously excrete millions of 
infectious virions every day of its life. Approximately 1% of one-year-old cattle are 
persistently infected. Transiently infected animals with high, long-lasting antibody 
levels and persistently infected animals with high levels of viraemia have provided 
important targets for diagnostic efforts (Houe et al., 2006). The most important factors 
of prevention are to detect and remove PI animals, avoid the introduction of BVDV 
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and minimize the possibility of the introduction (Bálint, 2005). The basis of 
eradication without vaccines is the recognition and removal of PI animals from the 
herds. The Scandinavian countries and also some other regions in Europe are aiming at 
complete eradication of BVDV without use of vaccines (Lindberg, 2003). 
In many countries, vaccines are used to control BVDV infections. Modern 
vaccination programs are designed not only to prevent clinical cases, but also to avoid 
viraemia and foetal infection. The inactivated, as well as, live vaccines may prevent 
foetal infection under controlled experimental conditions (Patel et al., 2002). 
Classical BVDV vaccines are of two different types; live attenuated and inactivated 
(Bálint, 2005; Graham et al., 2004). The attenuated vaccines can clinically protect 
immune-competent animals against viral challenge. Live attenuated vaccines did not 
protect completely against congenital infection, and vaccination of PI cattle did not 
protect from developing MD after superinfection with a cp strain. If the vaccine strain 
is closely related to the ncp BVDV strain in the PI animal, early onset of postvaccinal 
MD can occur, as it was observed several times. If the vaccine strain is not closely 
related to the persistently infecting ncp strain, during replication, the live vaccine strain 
might recombine in the PI animal with the respective ncp wild type strains of BVDV, 
and this recombination can lead to the development of the delayed onset of MD. A 
further disadvantage of the attenuated live virus vaccines is their immunosuppressive 
effect (Bálint, 2005; Coggins et al., 1961; Kecskeméti et al., 1998; Simonyi and Bíró, 
1967). 
The inactivated BVDV vaccines are safe, the original strains and the possible other 
agents are completely inactivated, thus, reversion to virulence and recombination after 
vaccination with the field virus strain is impossible. The inactivated vaccines are not 
immunosuppressive, and do not infect the foetus. The drawback of these vaccines is 
that they are expensive and during inactivation immunogenic activity can decrease 
(Makoschey et al., 2004).  
 
Eradication methods 
 
Eradication of BVD is possible with selection, generation change, or use of 
inactivated vaccines (Varga et al., 1999). During the 1990’s a systematic strategy to 
control BVDV, based on thorough knowledge of the epidemiology of the disease and, 
therefore, focused on prevention of foetal infection in early gestation, evolved within 
eradication programs in the Scandinavian countries (Lindberg and Alenius, 1999). 
PI animals are the main source of infection within the infected herd, because they 
shed virus in very high concentrations in all fluids of the body throughout their life 
(Moen et al., 2005). PI calf is immunotolerant to BVDV, generally seronegative, and 
shed large quantities of virus throughout its life. The key role of PI animals in the 
maintenance of infection within herd is further supported by vast empirical evidence 
from the Scandinavian BVDV control schemes, showing that virus circulation 
essentially stops as soon as the last PI animal is eliminated from the herd (Lindberg 
and Houe, 2005). Experiences from the Swedish BVDV control program have shown 
that self-clearance, i.e. the process whereby an infection is eliminated from a 
population without intervention, is an important and frequent phenomenon that works 
in favour of BVDV control (Stahl et al., 2008).  
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The Scandinavian strategy is based on three central elements: (1) biosecurity to 
avoid introduction of infection into BVDV free herds; (2) elimination of PI animals in 
infected herds to reduce virus circulation; and (3) continuous monitoring of free herds 
for early detection of reinfection (Lindberg and Alenius, 1999). The PI animals are 
seronegative, so in the Swedish method this has been used as a mean of identification, 
namely, after the individual serological tests, the seronegative individuals are 
virologically tested. There are other strategies for PI identification through direct virus 
detection, such as antigen testing of newborn calves by using e.g. ear-notch samples 
(Stahl and Alenius, 2012). 
Herd diagnosis is defined as diagnosis that is based on testing samples from 
multiple representative individuals in a herd. The common goal is to detect the 
presence or absence of a given disease within the herd without testing every animal 
separately. Diagnosis can involve testing several animals individually, or the pooling 
of samples (serum/plasma/milk) from several animals before testing. For BVDV, the 
following tests have been used on herd level diagnosis; 1) detection of antibodies in 
bulk milk; 2) detection of antibodies in individual or pooled serum/plasma samples 
from young stock or in pooled samples of milk or serum/plasma from primiparous 
cows; and 3) virus detection in bulk milk. If the antibody test using bulk milk and the 
spot tests of young stock indicate the presence of PI animals in the herd, the next step 
is to identify individual PI animals. The methods of continuous monitoring used to 
confirm infection-free status are essentially the same as those used to establish initial 
herd status. However, the accuracy of the relevant tests depends to a large extent on 
three situational factors: time period immediately after removal of PI animals 
(clearance); time and mode of herd re-infection; and re-emergence of PI animals (Houe 
et al., 2006). 
The Scandinavian BVDV control strategy had proved to be successful, thus, several 
other European countries have launched their control and eradication programs of 
BVD. Despite the different conditions at the start of the projects in terms of legal 
support, and regardless of initial prevalence of herds with PI animals, it took all 
countries approximately 10 years to reach their final stages (Stahl et al., 2008). Lower-
Austria launched a regional program on a voluntary basis in 1997, used the successful 
Scandinavian method. The program became compulsory in 2004 and extended to the 
entire country. In 2008 92% of all herds in Lower-Austria were certified as free from 
BVDV (Rossmanith et al., 2010). 
The eradication program was launched in 2008 in Switzerland applying an 
alternative approach. The Swiss compulsory program is based on the identification and 
removal of PI animals through antigen testing of all newborn calves. They do not use 
serological testing. The alternative approach was needful because of the very high 
initial seroprevalence, the high cattle density, the frequent cattle movements and the 
use of shared summer grazing in mountain pastures. In the first phase, which is the 
eradication phase, all cattle in the country were sampled (ear-notch or blood) and 
tested for antigen. 1.5 million cattle were tested and more than 12,000 PI animals were 
detected. In the second phase, which was called the calf phase, almost 700,000 calves, 
which were in the uterus during the first testing, were tested within five days of birth, 
and around another 5,000 PI animals were identified. The third phase, which is the 
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surveillance phase, is ongoing and carried out in accordance with the principles used in 
phase two. Until 2011, around 3.5 million animals have been tested and the prevalence 
of PI animals among newborn calves has decreased by 95% (Di Labio, 2011). 
A compulsory control program was introduced in all German states as of the 1st of 
January 2011. There is obligatory testing of all calves, with direct virus detection from 
ear-notch samples using ELISA or/and RT-PCR. In the BVD free herds voluntary 
vaccination is being applied (Gaede et al., 2004). The vaccination includes a first 
immunization with an inactivated vaccine and 4 weeks later a second immunization 
with a modified live virus vaccine, which is an element of biosecurity (Moennig et al., 
2005, Seeger et al., 2012). Mandatory eradication program launched in Scotland in 
2012, in Ireland in 2013 applying the Scandinavian method (Barrett et al., 2011; 
Becher et al., 2003; Graham et al., 2011). 
Large-scale control efforts have also implemented in Brittany in France (Joly et al., 
2005), in the Netherlands (Moen et al., 2005), in Germany (Moenning et al., 2005) and 
in the Lecco and Como regions of Italy (Luzzago et al., 2004). Time-limited, project-
type control efforts have also been implemented in the Rome area (Ferrari et al., 1999), 
as well as, in Greece (Billinis et al., 2005) and Galicia in Spain (Lindberg at al., 2006). 
 
Conclusions 
 
It is clear that unless BVDV control efforts are harmonized across Europe, there 
will always be a threat of spreading BVDV, including the less prevalent BVDV-2 and 
any new types that may emerge across the continent. Efficient systematic control 
measures with or without the use of vaccines will provide the necessary protection. A 
challenge for the future is to find a joint platform where differences in needs and 
preconditions between member states can be accommodated. The OIE has added 
BVDV to its list, a strong signal that the disease has become an international priority. 
The most important export markets of Hungary apply restrictive control measures 
as regards IBR and BVD, aiming at the prevention of import of infected animals and 
their animal products. The launch of a compulsory BVD eradication program in 
Hungary would mean a forward step to meet the animal health requirements of the 
international live animal and animal products trade. In order to achieve a successful 
eradication, national obligatory provisions should be applied to all cattle herds. 
Hungary would have a significant economic, environmental and animal welfare 
benefits if the disease was eradicated. One of the basic criteria for a successful 
eradication program is to detect and remove all the PI animals as soon as possible from 
the cattle herds. The rate of BVD infection increases with age. Hence those farmers, 
which are able to solve the detection and disposal of PI animals, and the separation of 
different age groups, can quickly complete the eradication among their calves.  
Based on the results of the latest survey in Hungary the prevalence of BVDV is 
smaller than expected. Therefore, it is possible the make a herd replacement of a very 
infected farm by using BVD free breeding animals from free herds to help starting a 
national eradication program. 
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